Northwestern Mutual just announced a record $9.2 billion dividend payout for 2026 — about a billion more than last year, and the largest three-year increase in the company's history. MassMutual is paying a record $2.9 billion, Guardian $1.7 billion, and New York Life $2.78 billion. Four of the five major mutual carriers raised their dividend interest rate again this year.

The easy explanation is the one everyone gives you: rates went up, so dividends went up. It's true, and it's lazy. If that were the whole story, this would be a two-minute episode. So we went digging instead.

In this one, we crack open the "general account" — the giant reservoir of patient money that sits behind every whole life policy in the country — and walk through what the investment teams are actually doing with your premium dollars. We cover the reinvestment tailwind (think of inheriting a ladder of your grandmother's CDs, where every maturing low-rate bond gets replaced at today's higher rates — slow, boring, and inevitable), why that same inertia is a feature and not a bug, and where the real yield edge comes from: private placements now approaching half of the industry's bond holdings, and the broader private-credit buildout that's become the story of the decade.

We also do the thing most people skip. We make the bear case. Private-credit valuations are model-driven and haven't been stress-tested through a real recession. A handful of large carriers hold most of the exposure. Office commercial real estate is still working itself out. And there's an important line we draw on-air: the PE-owned, annuity-heavy carriers driving most of that growth are not the mutual carriers writing participating whole life — Northwestern, MassMutual, New York Life, Guardian, and Penn are a different animal.

And two caveats we'll repeat because they matter: the dividend interest rate is not your policy's return — early years are dominated by acquisition costs, and an in-force illustration is the only honest read on an existing policy. And a good environment doesn't change who whole life is for. It's a stable, tax-advantaged, patient-capital sleeve within a broader plan — not a replacement for growth investing, nor a fix for a poorly designed policy. If that role fits what you're trying to do, the setup right now is about as favorable as it's been in fifteen years.

Have an existing policy you're not sure about, or wondering whether whole life fits the job you're trying to fill? We're happy to talk it through — no pitch, just a straight conversation. Send us a message or book a 30-minute call.

Most people think of life insurance as something that protects a plan they've already built. We'd argue it does something stranger and a lot more useful — it creates wealth on its own terms, and it starts doing the job on day one.

In this episode, we dig into the part of life insurance nobody spends enough time on: the death benefit. Not as a hedge against dying young, but as an active wealth-building tool that keeps working long after "replace my paycheck" stops being the reason to own the policy. It's about as life-insurancey as life insurance gets — and, for once, a good deal less technical than our usual fare.

What we get into:

• The instant estate. A modest premium creates a large, guaranteed, income-tax-free sum the day the policy is issued — you're buying dollars at a discount. No brokerage account, no piece of real estate can replicate that on day one.
• Replenishing wealth in retirement. Using a death benefit to refill a drawn-down portfolio at the exact moment a surviving spouse needs it most — and why Wade Pfau's research found this kind of backstop can free up roughly 22% more spending while you're alive.
• The Social Security gap. When one spouse dies, household benefits typically drop by 30–40% permanently. We talk about how life insurance buys the survivor time, breathing room, and a buffer against rushed decisions in an emotional fog.
• Long-term care. How accelerated death benefit riders for chronic conditions help defray care costs — without the "use it or lose it" problem of traditional long-term care coverage. (They're a supplement, not a replacement, and we say so.)
• The real cost of dying. Probate, funeral costs, carrying costs on illiquid real estate, retitling headaches — and why a death claim that pays in weeks beats an estate that takes months.

Here's the honest part: we're not claiming permanent insurance beats the market on raw return. It doesn't, and we'll tell you that plainly. The argument is narrower and more useful — there are specific jobs a portfolio structurally can't do, timed to the moment they matter most, that a death benefit does automatically. That's the difference between "protection" and "wealth building."

Think the death benefit you already own — or are weighing — might be doing more work than you realized? We'd be glad to help you figure out where it fits. Send us a message or book a 30-minute call, and we'll talk it through.

Heading into 2026, the federal estate tax exemption was scheduled to sunset and roughly cut in half. A lot of life insurance marketing was built around that deadline: set up an irrevocable life insurance trust (ILIT) and lock in coverage before the exemption dropped. Then the One Big Beautiful Bill Act, signed on July 4, 2025, canceled the sunset and set the exemption at $15 million per person — $30 million for a married couple — on a permanent basis, indexed for inflation.

In this episode, Brandon and Brantley walk through what has actually changed and who the federal estate tax applies to today. The exemption has grown by about 12.83% per year since 1999, from $650,000 to $15 million, while average farmland values grew by a little over fourfold over the same period. About 0.14% of estates owe federal estate tax, and under the feared reverted exemption, roughly 1% of farm estates would have owed the tax.

They also cover where permanent life insurance still does real work: large and illiquid estates facing a 40% tax due nine months after death; state-level estate and inheritance taxes with lower exemptions than the federal number; liquidity for probate and final expenses; equalizing an estate among heirs; and funding a buy-sell agreement.

Because an ILIT is irrevocable, the second half looks at what to do if you set one up and later decide you don't need it. Brandon and Brantley explain why unwinding a trust isn't as simple as asking for your money back, who the trustee owes a duty to, and how to re-examine a policy or trust you already own.

________________________________

Have a question about your own situation? Send us a message or book a quick call — we're happy to help.

There's a version of the life insurance conversation that comes with a velvet rope. Someone from the private client side of a bank or advisory firm tells you they have something they don't discuss with just anybody, and then they start explaining private placement life insurance.

We've been on the receiving end of that call. This week we walk through what PPLI actually is, why the pitch sounds so good, and why the math almost never gets there.

The concept is simple enough. Hedge funds and private equity throw off the kind of income that creates real tax headaches for high earners. So wrap the whole thing inside a life insurance policy and let the tax treatment of life insurance do the heavy lifting. If that sounds a lot like variable universal life to you, you're not wrong. Mechanically, it's the same animal with a different label on the investment sleeve.

The problem is what happened after the idea got popular. Webber v. Commissioner settled the question of whether you get to hand-pick the funds inside the policy. You don't. The investor control doctrine requires you to stay out of the selection process entirely, which means what you actually own is an insurance-dedicated fund — a fund of funds, buying pieces of whatever managers are willing to participate. The managers with money beating down their door generally aren't willing to participate. Which tells you something about what ends up on the menu.

Then there's everything else. A multi-million dollar, multi-year premium commitment you can't simply stop making. Less accessible cash value than a well-designed policy gives you. Insurance charges that run higher than what we see on indexed universal life, plus a separate layer of expense for owning the investments. And a very real possibility that the account goes down, because there's no floor under any of it.

We also get into the bill Senator Wyden introduced in April 2026, which would strip life insurance tax treatment from most private placement contracts and would apply to policies already in force. It probably isn't going anywhere in this Congress. But things like it have a way of hanging around, coming back, and eventually getting compromised into law in some smaller form.

Our conclusion after going through all of it: for nearly everyone being shown a PPLI proposal, a properly designed minimum non-MEC indexed universal life policy does the same job. Far less money required to start, far more access to your cash, and none of the compliance or legislative tail risk. Life insurance stands on its own merits. It doesn't need backroom secrecy to be worth owning.

Been pitched PPLI and want a second opinion? Send us a message and tell us what you're looking at, or book a call and we'll walk through the numbers with you.

If you've spent any time reading about indexed universal life insurance online, you already know the greatest hits. The insurance company will slash your cap whenever it feels like it. The illustration is a work of fiction. The policy will quietly implode under the rising cost of insurance. The "tax-free" retirement income strategy ends with a surprise tax bill on money you never actually saw. And the big one — eight out of ten IUL policies get thrown out within twenty years.

We've been at this for a couple of decades now, which means we've watched most of these predictions get made in real time. So on this episode we did something the critics rarely bother to do: we went looking for the evidence. Not the mechanism — yes, every one of these things can happen — but the incidence. How often does it actually happen?

What we found is an asymmetry worth talking about. A couple of these worries are legitimate and well documented. The gap between what a back-tested index promises and what it delivers once real money is on the line is real and measured. And the industry genuinely has spent more than a decade rewriting illustration rules to keep pace with product design.

But most of the scarier claims come with no data to back them up at all. The "8 out of 10 fail" number isn't in any published study we could find, and it doesn't even hold up under basic arithmetic. The exploding-cost-of-insurance horror stories are real for the handful of people they happened to — and completely unmeasured for everybody else.

We walk through all five worries, name who's making each argument, and separate what the evidence supports from what it merely lets you imagine. We're honest about the spots where the critics land a punch. And we get into the Kyle Busch–Pacific Life lawsuit, because you've probably seen the headline and almost certainly drawn the wrong conclusion from it.

Here's the through-line: almost every one of these worries describes something that can go wrong, and almost none of them tells you how often it does. That's not the same as saying nothing goes wrong. It means the real risks live in how a policy is designed, funded, and monitored — not in some conspiracy baked into the product itself.

_________________________________________

If you're trying to figure out whether an IUL policy fits your situation — or whether the one you already own was built the right way — we'd genuinely like to help. Send us a message with your questions, or book a call and let's talk it through.